CARsgen Therapeutics Holdings Limited (HKG:2171)

HKG:2171 Revenue

CARsgen Therapeutics Holdings had revenue of 61.92M CNY in the half year ending June 30, 2026, with 876.64% growth. This brings the company's revenue in the last twelve months to 136.62M, up 62.55% year-over-year. In the year 2025, CARsgen Therapeutics Holdings had annual revenue of 125.66M with 218.74% growth.

• Revenue (ttm): 136.62M CNY
• Revenue Growth: +62.55%
• P/S Ratio: 47.88
• Revenue / Employee: 322.22K CNY
• Employees: 424
• Market Cap: 7.55B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	125.66M	86.24M	218.74%
Dec 31, 2024	39.43M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	25.81M	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 18, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 9, 2026

Data Sources Report a data error